menu
    • menu

    Company profile for Somerset Pharmaceuticals Inc

    NEW Drugs in Dev: 1
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Somerset Pharmaceuticals, Inc. operates as a researcher and developer of Parkinson's disease pharmaceuticals. The company markets Eldepryl in capsule form for the treatment of patients with late-stage Parkinson's Disease. Somerset Pharmaceuticals, Inc. was founded in 1986 and is based in Tampa, Florida. Somerset Pharmaceuticals, Inc. operates as a subsidiary of Mylan, Inc.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Somerset Pharmaceuticals IncUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    5215 W. Laurel St. Tampa, FL 33607
    Telephone
    Telephone
    +1-813-288-0040
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.somersetpharm.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Somerset’ Generics Tofacitinib Citrate Receives Approval in US
    Somerset’ Generics Tofacitinib Citrate Receives Approval in US

    03 Jun 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220137

    FDA
    03 Jun 2026
    Share Share
    Somerset’ Generics Carboprost Tromethamine Receive Approval in US
    Somerset’ Generics Carboprost Tromethamine Receive Approval in US

    27 May 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219529

    FDA
    27 May 2026
    Share Share
    Xeris Bio Subsidiaries File Recorlev Patent Infringement Lawsuit
    Xeris Bio Subsidiaries File Recorlev Patent Infringement Lawsuit

    26 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260226546074/en/Xeris-Biopharma-Subsidiaries-File-Recorlev-Patent-Infringement-Lawsuit

    BUSINESSWIRE
    26 Feb 2026
    Share Share
    Somerset’s Receives First Generic Approval for Rilpivirine in US
    Somerset’s Receives First Generic Approval for Rilpivirine in US

    29 Jan 2026

    // FDA

    http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=218798

    FDA
    29 Jan 2026
    Share Share
    Somerset’ Generics Sacubitril & Valsartan Receives Approval in US
    Somerset’ Generics Sacubitril & Valsartan Receives Approval in US

    20 Jan 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219983

    FDA
    20 Jan 2026
    Share Share
    Somerset’ s Generics Eltrombopag Olamine Receives Approval in US
    Somerset’ s Generics Eltrombopag Olamine Receives Approval in US

    14 Jan 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219638

    FDA
    14 Jan 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search